References
- Brenner S, Goldberg I. Drug-induced pemphigus. Clin Dermatol 2011;29:455–457.
- Dal Negro RW. Erdosteine: antitussive and anti-inflammatory effects. Lung 2008;186 Suppl 1:S70–S73.
- Balli F, Bergamini B, Calistru P, et al. Clinical effects of erdosteine in the treatment of acute respiratory tract diseases in children. Int J Clin Pharmacol Ther 2007;45:16–22.
- Ogata K, Nakajima H, Ikeda M, et al. Drug-induced pemphigus foliaceus with features of pemphigus vulgaris. Br J Dermatol 2001;144:421–422.
- Cozzani E, Cacciapuoti M, Parodi A, et al. Pemphigus following tetanus and diphtheria vaccination. Br J Dermatol 2002;147:188–189.
- Heelan K, Shear NH. Cutaneous drug reactions in children: an update. Paediatr Drugs 2013;15:493–503.
- Yoshimura K, Ishii N, Hamada T, et al. Clinical and immunological profiles in 17 Japanese patients with drug-induced pemphigus studied at Kurume University. Br J Dermatol 2014;171:544–553.
- Landau M, Brenner S. Histopathologic findings in drug-induced pemphigus. Am J Dermatopathol 1997;19:411–414.
- Brenner S, Bialy-Golan A, Anhalt GJ. Recognition of pemphigus antigens in drug-induced pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 1997;36:919–923.
- Cetkovská P, Pizinger K. Childhood pemphigus associated with montelukast administration. Clin Exp Dermatol 2003;28:328–329.
- Ruocco V, De Angelis E, Lombardi ML. Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clin Dermatol 1993;11:507–513.